Molecular epidemiology of hepatitis C in Australia

Journal of Gastroenterology and Hepatology (Australia)

Volumn 13, Issue 9, 1998, Pages 914-920

  Kaba, Songul ^a   Dutta, Usha ^a,b   Byth, Karen ^a   Crewe, Evelyn B ^a   Khan, Mahbub H ^a,b   Coverdale, Shirley A ^a,b   Lin, Rita ^a,b   Liddle, Christopher ^a   Farrell, Geoffrey C ^a,b  

^a WESTMEAD HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Country of birth; Genotypes; Geographic distribution; Hepatitis C virus; Risk factors

Indexed keywords

ALANINE AMINOTRANSFERASE; VIRUS RNA;

ADULT; AGED; ARTICLE; ASIA; AUSTRALIA; BLOOD TRANSFUSION; CONTROLLED STUDY; EUROPE; FEMALE; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMIGRATION; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; NEW ZEALAND; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; REGRESSION ANALYSIS; RISK FACTOR; SEXUAL TRANSMISSION; TATTOOING; VIRUS ISOLATION; VIRUS TRANSMISSION;

EID: 0031750938     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1746.1998.tb00761.x     Document Type: Article

References (42)

1. Alter HJ, Purcell RH, Shih JW et al. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A non-B hepatitis. N. Engl. J. Med. 1989; 321: 1494-500.
2. Di Bisceglie AM, Goodman ZD, Ishak KG, Hoofnagle JH, Melpolder JJ, Alter HJ. Long-term clinical and histopathological follow-up of chronic post-transfusion hepatitis. Hepatology 1991; 14: 969-74.
3. Seeff LB. Natural history of viral hepatitis, type C. Semin. Gastrointest. Dis. 1995; 6: 20-7.
4. Fattovich G, Giustina G, Degos F et al. Morbidity and mortality in compensated cirrhosis type C: A retrospective follow-up study of 384 patients. Gastroenterology 1997; 112: 463-72.
5. Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet 1997; 349: 825-32.
6. Choo QL, Richman KH, Han JH et al. Genetic organisation and diversity of hepatitis C virus. Proc. Natl Acad. Sci. USA 1991; 88: 2451-5.
7. Brechot C. Hepatitis C virus: Molecular biology and genetic variability. Dig. Dis. Sci. 1996; 41 (Suppl. 12): S6-21.
8. Mellor J, Holmes EC, Jarvis LM, Yap PL, Simmonds P and The International HCV Collaborative Study Group. Investigation of pattern of hepatitis C virus sequence diversity in different geographical regions: Implications for virus classification. J. Gen.Virol. 1995; 76: 2493-507.
9. Bukh J, Miller RH, Purcell RH. Genetic heterogeneity of hepatitis C virus: Quasispecies and genotypes. Semin. Liver. Dis. 1995; 15: 41-63.
10. Simmonds P. Variability of hepatitis C virus. Hepatology 1995; 21: 570-83.
11. Major ME, Feinstone SM. The molecular virology of hepatitis C. Hepatology 1997; 25: 1527-38.
12. Zein NN, Rakela J, Persing DH. Genotype-dependent serologic reactivities in patients infected with hepatitis C virus in the United States. Mayo Clin. Proc. 1995; 70: 449-52.
13. Nousbaum JB, Pol S, Nalpas B, Landais P, Berthelot P, Brechot C. Hepatitis C virus type 1b (II) infection in France and Italy. Collaborative Study Group. Ann. Intern. Med. 1995; 122: 161-8.
14. Yoshioka K, Kakamu S, Wakita T et al. Detection of hepatitis C virus by polymerase chain reaction and response to interferon-alpha therapy: Relationship to genotypes of hepatitis C virus. Hepatology 1992; 16: 293-9.
15. Lin R, Liddle C, Byth K, Farrell GC. Virus and host factors are both important determinants of response to interferon treatment among patients with chronic hepatitis C. J. Viral Hepatitis 1996; 3: 85-96.
16. Bruno S, Silini E, Crosignani A et al. Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: A prospective study. Hepatology 1997; 25: 754-8.
17. Silini E, Bottelli R, Asti M et al. Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: A case-control study. Gastroenterology 1996; 111: 199-205.
18. Martin P. Hepatitis C genotypes: The key to pathogenicity? Ann. Intern. Med. 1995; 122: 227-8.
19. Dubois F, Desenclos J-C, Mariotte N, Goudeau A and The Collaborative Study Group. Hepatitis C in French population-based survey, 1994: Seroprevalence, frequency of viremia, genotype distribution and risk factors. Hepatology 1997; 25: 1490-6.
20. Angelico M, Renganathan E, Gandin C et al. Chronic liver disease in Alexandria governorate, Egypt: Contribution of schistosomiasis and hepatitis virus infection. J. Hepatol. 1997; 26: 236-43.
21. Matar GM, Sharara HM, Abdelnour GE, Abdelnour AM. Genotyping of hepatitis C isolates from Lebanese hemodialysis patients by reverse transcription-PCR and restriction fragment length polymorphism analysis of 5′ noncoding region. J. Clin. Microbiol. 1996; 34: 2623-4.
22. Dusheiko G, Schimilovitz-Weiss H, Brown D et al. Hepatitis C virus genotypes: An investigation of type specific difference in geographic origin and disease. Hepatology 1994; 19: 13-18.
23. Simmonds P, Mellor J, Craxi A et al. Epidemiological, clinical and therapeutic associations of hepatitis C types in western European patients. J. Hepatol. 1996; 24: 517-24.
24. McOmish F, Chan SW, Dow BC et al. Detection of three types of hepatitis C virus in blood donors: Investigation of type-specific differences in serologic reactivity and rate of alanine aminotransferase abnormalities. Transfusion 1993; 33: 7-13.
25. Qu D, Li JS, Vitvitski L et al. Hepatitis C virus genotypes in France: Comparison of clinical features of patients infected with HCV type I and type II. J. Hepatol. 1994; 21: 70-5.
26. Driesel G, Wirth D, Stark K, Baumgarten R, Sucker U, Schreier E. Hepatitis C virus (HCV) genotype distribution in German isolates: Studies on the sequence variability in the E2 and NS5 region. Arch. Virol. 1994; 139: 379-88.
27. Pistello M, Maggi F, Vatteroni L et al. Prevalence of hepatitis C virus genotypes in Italy. J. Clin. Microbiol. 1994; 32: 232-4.
28. Sharara AL, Hunt CM, Hamilton JD. Hepatitis C. Ann. Intern. Med. 1996; 125: 658-68.
29. Lin R, Roach E, Zimmerman M, Strasser S, Farrell GC. Interferon alpha-2b for chronic hepatitis C: Effects of dose increment and duration of treatment on response rates. J. Hepatol. 1995; 23: 487-96.
30. Lin R, Schoeman MN, Craig PI et al. Can the response to interferon treatment be predicted in patients with chronic active hepatitis C? Aust. NZ J. Med. 1991; 21: 387-92.
31. The Australian Hepatitis C study group. Efficacy and tolerance of a 6-month treatment course of daily interferon-α2a for chronic hepatitis C with cirrhosis. J. Viral Hepatitis 1997; 4: 317-23.
32. Pocock SJ. Clinical trials. Further aspects of data analysis. In: Logit analysis in Statistical Methods for Comparative Studies: Techniques for Bias analysis. Chichester: John Wiley and Sons, 1980; 218-19.
33. Mison LM, Young IF, O'Donoghue M, Cowley N, Thorlton N, Hyland CA. Prevalence of hepatitis C virus and genotype distribution in an Australian volunteer blood donor population. Transfusion 1997; 37: 73-8.
34. McOmish F, Yap PL, Dow BC et al. Geographical distribution of hepatitis C virus genotypes in blood donors: An international collaborative survey. J. Clin. Microbiol. 1994; 32: 884-92.
35. el-Zayadi A, Simmonds P, Dabbous H, Prescott L, Selim O, Ahdy A. Response to interferon-alpha of Egyptian patients infected with hepatitis C virus genotype 4. J. Viral Hepatitis 1996; 3: 261-4.
36. Moaven LD, Crofts N, McCaw R, Bowden DS. The changing prevalence of hepatitis C virus types in injecting drug users between 1971 and 1994. Med. J. Aust. 1996; 165: 233 (Letter).
37. Chen J, McGuinness PH, Koorey DJ, Rickard K, McCaughan GW. Hepatitis C virus genotypes in a cohort of Australian blood donors and haemophiliac and liver transplant patients. J. Gastroenterol. Hepatol. 1997; 12: 182-7.
38. Guido M, Rugge M, Thung SN et al. Hepatitis C serotypes and liver pathology. Liver 1996; 16: 353-7.
39. Zein NN, Persing DH. Hepatitis C genotypes: Current trends and future implications. Mayo Clin. Proc. 1996; 71: 458-62.
40. Berg T, Hopf U, Stark K, Baumgarten R, Lobeck H, Schreier E. Distribution of hepatitis C genotypes in German patients with chronic hepatitis C: Correlation with clinical and virological parameters. J. Hepatol. 1997; 26: 484-91.
41. Strasser SI, Watson KJR, Lee CS, Coghlan PJ, Desmond PV. Risk factor and predictors of outcome in an Australian cohort with hepatitis C virus infection. Med. J. Aust. 1995; 162: 355-8.
42. Bell J, Batey RG, Farrell GC, Crewe EB, Cunningham AL, Byth K. Hepatitis C virus in intravenous drug users. Med. J. Aust. 1990; 153: 274-6.